GILEAD SCIENCES, INC.

PublicCIK: 882095
GILDNASDAQ
Location

FOSTER CITY, CA

📋 What this filing means

GILEAD SCIENCES, INC. filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $1.65B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

5
Positions
$1.65B
Total AUM (reported)
57.89M
Total Shares

Allocation by class

TOTAL AUM$1.65B5 positions
COM$1.01B61.4%
SPON ADR$500.16M30.3%
COM NEW$136.77M8.3%

Portfolio Concentration

Top 397.4%4–102.6%TOP 10100.0%0%100%
Top 3$1.61B97.4%
4–10$42.99M2.6%

Top 3 weight

97.4%

Top 10 weight

100.0%

Voting Authority Distribution

Total shares with voting rights: 57.89M

Sole

Full voting authority

57.89M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:

Arcus Biosciences Inc.

SOLE
COM
Shares31.42M
TypeSH
Market value$968.83M
58.76%
Sole
31.42M
Shared
0.00
None
0.00

Lakefront Biotherapeutics

SOLE
SPON ADR
Shares16.71M
TypeSH
Market value$500.16M
30.34%
Sole
16.71M
Shared
0.00
None
0.00

Assembly Biosciences Inc.

SOLE
COM NEW
Shares4.98M
TypeSH
Market value$136.77M
8.30%
Sole
4.98M
Shared
0.00
None
0.00

Kyverna Therapeutics Inc.

SOLE
COM
Shares4.13M
TypeSH
Market value$36.76M
2.23%
Sole
4.13M
Shared
0.00
None
0.00

Xilio Therapeutics Inc.

SOLE
COM
Shares650.39K
TypeSH
Market value$6.23M
0.38%
Sole
650.39K
Shared
0.00
None
0.00